advertisement
Lin MK 13
Showing records 1 to 13 | Display all abstracts from Lin MK106854 Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Chen XL
International Journal of Ophthalmology 2023; 16: 108-114
106684 Evaluation of the learning curve of laser peripheral iridectomy: the 20 case reaches the turning point
Liu Y; Zhou YY
International Journal of Ophthalmology 2022; 15: 1960-1965
106854 Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Fu YJ
International Journal of Ophthalmology 2023; 16: 108-114
106684 Evaluation of the learning curve of laser peripheral iridectomy: the 20 case reaches the turning point
Zuo CG
International Journal of Ophthalmology 2022; 15: 1960-1965
106854 Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Qu B
International Journal of Ophthalmology 2023; 16: 108-114
106684 Evaluation of the learning curve of laser peripheral iridectomy: the 20 case reaches the turning point
Liao YR
International Journal of Ophthalmology 2022; 15: 1960-1965
106854 Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Wang YW; Tang X
International Journal of Ophthalmology 2023; 16: 108-114
106684 Evaluation of the learning curve of laser peripheral iridectomy: the 20 case reaches the turning point
Ren JW
International Journal of Ophthalmology 2022; 15: 1960-1965
106854 Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Wang YH
International Journal of Ophthalmology 2023; 16: 108-114
106684 Evaluation of the learning curve of laser peripheral iridectomy: the 20 case reaches the turning point
Lin HS
International Journal of Ophthalmology 2022; 15: 1960-1965
106854 Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Zhou GY
International Journal of Ophthalmology 2023; 16: 108-114
106684 Evaluation of the learning curve of laser peripheral iridectomy: the 20 case reaches the turning point
Gao XB; Lin MK
International Journal of Ophthalmology 2022; 15: 1960-1965
106854 Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Lin MK; Shen JY; Yao J; Li SY; Wu MQ; Peng HZ; Lai MY; Wu RY; Zhang YN; Li Y; Wu XJ; Zhang MC; Guo SP; Sun XH
International Journal of Ophthalmology 2023; 16: 108-114
